NewsStateState-Ohio

Actions

Ohio tightens rules to limit suspicious drug distribution

Posted at 12:53 PM, Feb 01, 2018
and last updated 2018-02-01 19:40:14-05

COLUMBUS, Ohio (AP) — Companies that fill prescription drug orders would have to report more information about suspicious orders to Ohio regulators and do it faster, as part of the state’s fight against the deadly opioid epidemic.

The proposed rules were announced by Gov. John Kasich on Thursday. He said they would "make it clear you cannot go willy-nilly prescribing these pills."

The state also wants to require that drug distributors do a better job researching their customers and to hold onto suspicious orders until questions are answered about the drugs’ destination.

RELATED: 65 Ohio, Kentucky counties sue drug distributors in 2017 over opioid damage

Companies that don’t comply could have their drug distribution license for Ohio revoked. Red flags could be large orders of controlled substances like pain pills or cash-only orders.

“You have to know your customer,” the Republican Kasich said. “If you know that a particular pharmacy is receiving an inordinate increase in the number of pills that they normally do, we want to know about that.”

 

 

 

The rules are open for public input and wouldn’t take effect for three to four months. They would be tougher than current federal standards, which are considered vague, said Megan Marchal, president of the state pharmacy board and a pharmacist at Ohio State’s medical center.

"We're going to enhance the requirements on drug wholesalers for monitoring and reporting suspicious orders of controlled substances," Marchal said. "They will build on the comprehensive efforts to stem the tide of opiate abuse in Ohio."

Pharmacy board officials say Ohio’s rules are needed in part because of a 2016 federal law they say considerably weakened the Drug Enforcement Administration’s ability to freeze suspicious narcotic shipments from drug distributors.

Ohio’s rules will be the strongest in the country, said Carmen Catizone, executive director of the National Association of Boards of Pharmacy.

Other states require the reporting of suspicious orders, but are often buried in the responses which come in a variety of forms and are up to state pharmacy boards to interpret, Catizone said Thursday.

Ohio is creating a uniform system that gives companies clear guidelines for reporting, he said. Kasich told 9 On Your Side he wants Ohio to be a model for the country.

"This, frankly, is something the entire nation should adopt," Kasich said. "As the president looks to do something about opioids, he ought to look to Ohio."

Drug overdoses killed a record 4,050 Ohioans in 2016, with 2017 numbers expected to be higher.

ANALYSIS: Meet the opioid wholesalers who became middlemen for the heroin epidemic

Despite those fatalities, the state is making progress cracking down on prescription painkiller abuse, thanks to new regulation of prescriptions for pain.

Deaths from painkillers — as opposed to heroin or the even deadlier fentanyl — are at a six-year low. The number of painkillers prescribed in Ohio dropped 162 million from 2012 to 2016.

"The thing that frustrates me is, we're beginning to see some progress and people need to know because the headlines are always 'it's out of control' or 'it's terrible,' but it's not like we're not starting to see the clearing," Kasich said. "These things are beginning to work for us."

Street drugs like illegal fentanyl — different from legal pain patches given terminally ill patients — are driving current overdose increases.

"We're spending about a billion dollars fighting this," Kasich said. "We are seeing progress, but the time has come for our community to keel the devil that lurks in our streets."

Several drug distributors are named in lawsuits pending in a federal court in Cleveland, where numerous cities and counties accuse the companies of not doing enough to monitor suspicious sales.

The companies have said they don’t believe litigation is the answer but have pledged to help solve the crisis.